Moors & Cabot’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,073
Closed -$227K 867
2021
Q2
$227K Buy
+6,073
New +$227K 0.02% 684
2020
Q3
Sell
-8,100
Closed -$206K 710
2020
Q2
$206K Buy
+8,100
New +$206K 0.02% 574